ATE405555T1 - Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthält - Google Patents
Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthältInfo
- Publication number
- ATE405555T1 ATE405555T1 AT02700580T AT02700580T ATE405555T1 AT E405555 T1 ATE405555 T1 AT E405555T1 AT 02700580 T AT02700580 T AT 02700580T AT 02700580 T AT02700580 T AT 02700580T AT E405555 T1 ATE405555 T1 AT E405555T1
- Authority
- AT
- Austria
- Prior art keywords
- composition containing
- medical composition
- thiazine derivative
- optionally substituted
- thiazine
- Prior art date
Links
- 150000000187 1,3-thiazines Chemical class 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000027455 binding Effects 0.000 abstract 1
- 229930003827 cannabinoid Natural products 0.000 abstract 1
- 239000003557 cannabinoid Substances 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
- C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001065386 | 2001-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE405555T1 true ATE405555T1 (de) | 2008-09-15 |
Family
ID=18924048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02700580T ATE405555T1 (de) | 2001-03-08 | 2002-02-14 | Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthält |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6916806B2 (de) |
| EP (1) | EP1375489B1 (de) |
| JP (1) | JP4188694B2 (de) |
| KR (2) | KR100642570B1 (de) |
| CN (1) | CN1301981C (de) |
| AT (1) | ATE405555T1 (de) |
| BR (1) | BR0207966A (de) |
| CA (1) | CA2440186C (de) |
| DE (1) | DE60228429D1 (de) |
| MX (1) | MXPA03008033A (de) |
| WO (1) | WO2002072562A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60038687T2 (de) * | 1999-09-14 | 2009-05-28 | Shionogi & Co., Ltd. | 2-imino-1,3-thiazin-derivate |
| US20050101590A1 (en) * | 2002-02-19 | 2005-05-12 | Kiyoshi Yasui | Antipruritics |
| AU2003217961B2 (en) | 2002-03-08 | 2008-02-28 | Signal Pharmaceuticals, Llc | Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| EP1661572A1 (de) * | 2003-08-18 | 2006-05-31 | Shionogi & Co., Ltd. | Neue verwendung von cannabinoid-rezeptor-agonisten |
| TW200508211A (en) | 2003-08-26 | 2005-03-01 | Shionogi & Co | 2-naphthylimino-1,3-thiazine derivatives |
| US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
| JPWO2006080284A1 (ja) * | 2005-01-25 | 2008-06-19 | 塩野義製薬株式会社 | ２−置換イミノ−１，３−オキサジン誘導体 |
| WO2006080287A1 (ja) * | 2005-01-25 | 2006-08-03 | Shionogi & Co., Ltd. | ２－アゾリルイミノ－１，３－チアジン誘導体 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6165894A (ja) | 1984-09-08 | 1986-04-04 | Shionogi & Co Ltd | チアジンホスホン酸誘導体とその製法および殺虫剤 |
| JPS6229594A (ja) | 1985-07-31 | 1987-02-07 | Shionogi & Co Ltd | チアジン環を有する有機燐化合物 |
| JPS62120374A (ja) | 1985-11-20 | 1987-06-01 | Yoshitomi Pharmaceut Ind Ltd | １，３−チアジンまたは１，３−オキサジン誘導体 |
| NL8702437A (nl) * | 1987-10-13 | 1989-05-01 | Geo Kinetics B V I O | Werkwijze voor het conditioneren van grondmateriaal door elektrokinetische behandeling, elektrisch stroomsysteem voor toepassing van de werkwijze alsmede elektrode-behuizing voor toepassing in het elektrische stroomsysteem. |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| US5194434A (en) | 1991-12-03 | 1993-03-16 | Texas A&M University System | Use of OB-101 to treat ocular inflammation |
| AU1618697A (en) | 1996-02-06 | 1997-08-28 | Japan Tobacco Inc. | Novel compounds and pharmaceutical use thereof |
| CA2283797A1 (en) | 1997-03-18 | 1998-09-24 | Paul Elliot Bender | Novel cannabinoid receptor agonists |
| AU8127998A (en) | 1997-07-11 | 1999-02-08 | Japan Tobacco Inc. | Quinoline compounds and medicinal uses thereof |
| DE19837627A1 (de) | 1998-08-19 | 2000-02-24 | Bayer Ag | Neue Aminosäureester von Arylsulfonamiden und Analoga |
| HUP0105134A2 (hu) * | 1999-01-14 | 2002-04-29 | Bayer Corporation | Szubsztituált 2-arilimino-heterociklusok és ilyen vegyületeket tartalmazó készítmények progeszteron receptorhoz kötődő szerekként való alkalmazásra |
| DE60038687T2 (de) | 1999-09-14 | 2009-05-28 | Shionogi & Co., Ltd. | 2-imino-1,3-thiazin-derivate |
-
2002
- 2002-02-14 BR BR0207966-6A patent/BR0207966A/pt not_active IP Right Cessation
- 2002-02-14 MX MXPA03008033A patent/MXPA03008033A/es active IP Right Grant
- 2002-02-14 AT AT02700580T patent/ATE405555T1/de not_active IP Right Cessation
- 2002-02-14 JP JP2002571478A patent/JP4188694B2/ja not_active Expired - Fee Related
- 2002-02-14 KR KR1020037011711A patent/KR100642570B1/ko not_active Expired - Fee Related
- 2002-02-14 CA CA002440186A patent/CA2440186C/en not_active Expired - Fee Related
- 2002-02-14 US US10/470,388 patent/US6916806B2/en not_active Expired - Fee Related
- 2002-02-14 KR KR1020067005884A patent/KR20060029296A/ko not_active Withdrawn
- 2002-02-14 DE DE60228429T patent/DE60228429D1/de not_active Expired - Lifetime
- 2002-02-14 CN CNB028062108A patent/CN1301981C/zh not_active Expired - Fee Related
- 2002-02-14 WO PCT/JP2002/001229 patent/WO2002072562A1/ja not_active Ceased
- 2002-02-14 EP EP02700580A patent/EP1375489B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002072562A1 (en) | 2002-09-19 |
| KR100642570B1 (ko) | 2006-11-10 |
| US6916806B2 (en) | 2005-07-12 |
| CN1301981C (zh) | 2007-02-28 |
| JP4188694B2 (ja) | 2008-11-26 |
| EP1375489A4 (de) | 2005-03-02 |
| EP1375489B1 (de) | 2008-08-20 |
| DE60228429D1 (de) | 2008-10-02 |
| US20040116326A1 (en) | 2004-06-17 |
| EP1375489A1 (de) | 2004-01-02 |
| CA2440186C (en) | 2009-01-13 |
| BR0207966A (pt) | 2004-06-15 |
| KR20040007462A (ko) | 2004-01-24 |
| JPWO2002072562A1 (ja) | 2004-07-02 |
| MXPA03008033A (es) | 2003-12-04 |
| KR20060029296A (ko) | 2006-04-05 |
| CA2440186A1 (en) | 2002-09-19 |
| CN1514831A (zh) | 2004-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953305D0 (no) | Antranilsyrederivat | |
| NO20033385L (no) | Fuserte heterocykliske forbindelser | |
| DE60038687D1 (de) | 2-imino-1,3-thiazin-derivate | |
| DE69418243D1 (de) | N-Heteroaryl-N'-Phenylharnstoffderivate, ihre Herstellung und Verwendung | |
| ATE190052T1 (de) | Thiazolidindione-derivate, ihre herstellung und verwendung | |
| FI973207A0 (fi) | Heterosyklisiä yhdisteitä | |
| DE69929669D1 (de) | Zyklische Amidderivate die Cathepsin K hemmen | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| ATE289810T1 (de) | Ecteinascidinderivate | |
| TR199500954A1 (tr) | Yeni pirokarbazoller. | |
| ATE183189T1 (de) | Antifungale sordaridinderivate | |
| ATE122344T1 (de) | Naphthyloxazolidon-derivate. | |
| DE60228429D1 (de) | Medizinische zusammensetzung, die ein 1,3-thiazinderivat enthält | |
| DE69937045D1 (de) | Cyclische amidderivate | |
| DK1031556T3 (da) | 2-phenoxyanilinderivater | |
| DK1559714T3 (da) | Fremgangsmåde til fremstilling af 2-alkyl-3-aminothiophenderivater og 3-aminothiophenderivater | |
| TR200200347T2 (tr) | 1,4-İkameli 4,4-diaril sikloheksanlar. | |
| AU6594900A (en) | Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof andagents | |
| CA2297112A1 (en) | Dicyclanil polymorphs and hydrates and their preparation | |
| DE69906243T2 (de) | 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe | |
| ATE340175T1 (de) | Imidazo(4,5-böchinolinderivate und ihre verwendung als inhibitoren der induzierbaren no- synthase | |
| AU2319000A (en) | Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof | |
| TH26544A (th) | อนุพันธ์กรด -4 - อัลคิลไทโอ -ไพรมิดิน -5 - อิล อาซีติก |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |